Be part of the knowledge.™
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. FDA Drug Information Updates

Understanding the Naming Policy for Salt Drug Substances

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Comments

  • Overview

    FDA Drug Info Rounds pharmacists discuss the application of the United States Pharmacopeia’s Monograph Naming Policy for Salt Drug Substances in Drug Products and Compounded Preparations (USP Salt Policy) by FDA’s Center for Drug Evaluation and Research.

    Learn more of the FDA Drug Info Rounds.

Recommended
Details
Comments

  • Overview

    FDA Drug Info Rounds pharmacists discuss the application of the United States Pharmacopeia’s Monograph Naming Policy for Salt Drug Substances in Drug Products and Compounded Preparations (USP Salt Policy) by FDA’s Center for Drug Evaluation and Research.

    Learn more of the FDA Drug Info Rounds.

Schedule23 Oct 2024
PrevNext

Program Chapters

Segment Chapters

Playlist:

Recommended